<DOC>
	<DOCNO>NCT00923065</DOCNO>
	<brief_summary>This study provide cancer care National Cancer Institute 's Medical Oncology Branch ( MOB ) patient enrol active treatment research protocol . Patients receive standard treatment ; investigational therapy provide protocol . Patients 18 year age old may eligible protocol . Candidates patient NCI investigator decide interest patient NCI best serve patient 's enrollment protocol receive care follow-up within MOB . This include patient follow category : - Patients previously enrol NCI trial whose participation protocol may continue provide researcher important scientific information - Patients eligible research protocol within foreseeable future - Patients whose medical welfare seriously compromise referral back community , patient rare complex disease community resource inadequate unavailable - Terminally ill patient receive specialized medical care Clinical Center humanitarian consideration dictate continue receive medical care NIH go study remain week month life - Patients cancer HIV , people risk cancer HIV cancer treatment NCI request MOB consult service - Patients participate non-treatment NCI research protocol require standard-of-care therapy - Patients cancer HIV people risk cancer cancer treatment management NCI would add significant value institute 's cancer training program Participants receive standard medical care , include periodic routine laboratory test , diagnostic x-ray , nuclear medicine scan monitor course illness effect treatment .</brief_summary>
	<brief_title>Cancer Care National Cancer Institute Center Cancer Research</brief_title>
	<detailed_description>Background : It may interest Center Cancer Research ( CCR ) treat and/or follow certain subject currently enrol active research protocol . Objective : The objective protocol add value medical surgical oncology training program provide treatment medical follow-up NCI patient Institute consult patient currently enrol active research protocol . Eligibility : It best interest subject CCR subject receive treatment NCI , NIH Intramural Research Program . Design : No investigational therapy administer study . This protocol platform perform pilot study off-label us standard agent . This protocol provide administrative vehicle provide cancer care patient intramural research program . Medical/surgical/radiotherapeutic care , treatment follow-up provided subject currently enrol active protocol .</detailed_description>
	<criteria>INCLUSION CRITERIA : Patient must age 18 older . A CCR investigator decide best interest patient CCR subject receive treatment followup NCI/NIH . The patient Legally Authorized Representative able willing provide inform consent . EXCLUSION CRITERIA : Subjects receive investigational therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 29, 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Oncology</keyword>
	<keyword>Standard Care</keyword>
</DOC>